This milestone builds on Clarity's earlier receipt of 2 FTDs for the diagnostic 64 Cu-SAR-bisPSMA in patients with suspected metastasis of prostate cancer who are candidates for initial definitive ...
This milestone builds on Clarity's earlier receipt of an FTD for 64 Cu-SAR-bisPSMA in patients with suspected metastasis of prostate cancer who are candidates for initial definitive therapy [1]. These ...
LOS ANGELES, July 09, 2025 (GLOBE NEWSWIRE) -- Trethera Corporation ("Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, ...
The US Food and Drug Administration (FDA) has green-lit the fast-tracking of an innovative personalized treatment for advanced prostate cancer following a promising clinical trial where the cancer ...
Cancer Research UK-funded scientists have developed a new way to test the effectiveness of a drug for prostate cancer that has spread to the bone, which is currently incurable, according to research ...
WEST PALM BEACH, Fla. — September is Prostate Cancer Awareness Month, and WPTV is helping men navigate their prostate health, from the two tests that every man needs to a new procedure that's offering ...
MINNEAPOLIS--(BUSINESS WIRE)--In 2012, Dr. Jafar Golzarian performed the first prostate artery embolization (PAE) in the U.S. Today, he is confidently performing PAE on an outpatient basis at North ...
“As a two-time prostate cancer survivor, I enjoy today as if it will be my last,” Jesse said. “I engage every man I meet ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback